Cipla | CIPLA - Cost Of Sales

Stock Price
1,318.60
Daily Change
12.10 0.93%
Monthly
7.71%
Yearly
-14.93%
Q2 Forecast
1,266.51

Cipla reported INR29.1B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
aTyr Pharma USD 3.34M 18.79M Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Esperion Therapeutics USD 27.85M 13.43M Dec/2025
Infinity Pharmaceuticals USD 352K 89K Jun/2023
Minerva Neurosciences 386K 31K Jun/2024
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
TherapeuticsMD USD -11.99M 12.34M Dec/2022
UPL INR 66.73B 1.49B Dec/2025